BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  FDA

  Lamassu Bio Unveils New Venture to Accelerate Cancer Therapeutics

  Lamassu Bio, Inc. is setting its sights on the unmet needs of the pharmaceutical industry as it announces a new venture to develop therapeutics for cancer.

  March 18, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Drug Development

  New Alzheimer’s Insights: Potential Role of Lithium, Correlation to Naps

  With the International Conference on Alzheimer’s and Parkinson’s Diseases still ongoing, there has been increased news about Alzheimer’s. Here’s a look at just a few of the latest stories.

  March 18, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Policy

  Martin Shkreli Cannot Delay Paying Nearly $25 Million in Civil Penalties

  Martin Shkreli will not be able to delay paying nearly $25 million he owes from a civil lawsuit that he and his company employed on Daraprim.

  March 18, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Clinical Catch-Up: New SMA and Alzheimer’s Data

  It was a busy week for clinical trial announcements. Here’s a look.

  March 18, 2022

   · 

  10 min read

   · 

  Mark Terry
• 

  Policy

  JHL’s Judas Kiss: an Inside Look at JHL Biotech’s Theft from Genentech

  A closer look at legal action against executives from the company formerly known as JHL Biotech who recruited scientists from Genentech to steal trade secrets related to several cancer drugs.

  March 18, 2022

   · 

  5 min read

   · 

  Alex Keown
• 

  Business

  Three Biopharma Companies Heading to Nasdaq Through SPACs

  California-based Apexigen and two other companies are planning to move to the Nasdaq Stock Exchange following their mergers with SPACs.

  March 18, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Merck’s Keytruda Delivers Reduced Risk of Death in Adjuvant NSCLC

  Merck announced that its proposed treatment Keytruda for non-small cell lung cancer delivered positive results from its Phase III trial.

  March 18, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Former Athira CEO Leen Kawas Reemerges at Startup Propel Bio Partners

  Following her ouster as CEO of Athira Pharma, Leen Kawas has co-founded Propel Bio Partners, an equity investment firm focused on helping other life sciences companies.

  March 18, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  How to Effectively Manage and Hire Interns

  Learn how to successfully hire interns. Also, find some tips on how to manage and support both in-office and remote interns in our comprehensive guide.

  March 18, 2022

   · 

  5 min read

   · 

  Franklin Carpenter
• 

  Drug Development

  Modern Age of Alzheimer’s Research on Display at 2022 International Conference

  The data showed mixed end results, but the diagnostics involved in treating Alzheimer’s were the star of the conference.

  March 18, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh